i.lehtinen
TL2 Moderator · Kochi
Contributes reviews on supplier material. Based in Kochi.
Joined 30 September 2024 · last posted 3d
84 posts, newest first. Showing up to 150.
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #75 · Clinical › Prescriber conversations · 25 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #26 · Analytics › Home & field testing · 23 Jul 2026 · 18 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
Restarting after a long gap: what the labelling implies Replied, post #36 · Practice › Dosing & titration · 21 Jul 2026 · 15 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Follow-up: Signs of dehydration worth acting on Replied, post #22 · Safety › Adverse events · 12 Jul 2026 · 0 likes Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion with a mental health professional. These are rare but real.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #56 · Compounds › Retatrutide · 12 Jul 2026 · 14 likes post #55 is right about the mechanism and I think understates the practical bit. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is…
-
The anatomy of a question that gets answered within an hour Replied, post #109 · Start Here › How to Ask · 12 Jul 2026 · 0 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #119 · Start Here › How to Ask · 11 Jul 2026 · 1 like Picking up post #116: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Tracking intake honestly when appetite is absent Replied, post #89 · Nutrition & Training › Protein & intake · 7 Jul 2026 · 28 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #53 · Analytics › Impurities & related substances · 6 Jul 2026 · 27 likes post #52 is right about the mechanism and I think understates the practical bit. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier.…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #67 · Analytics › Home & field testing · 5 Jul 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #7 · Evidence › Study critique · 4 Jul 2026 · 18 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
Racemisation and why it is invisible to a mass measurement Replied, post #126 · Analytics › Impurities & related substances · 15 Jun 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Documenting a payment dispute without naming and shaming — the long version Replied, post #3 · Sourcing › Payments · 13 Jun 2026 · 32 likes Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are taking a risk. Reputation and history of other buyers matter.
-
Fixed versus detachable needles: the trade-offs — does this still hold? Replied, post #6 · Devices › Syringes & needles · 4 Jun 2026 · 7 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Transporting a vial for a weekend away — a second dataset Replied, post #72 · Practice › Storage & stability · 4 Jun 2026 · 8 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Conditions that change the calculus rather than forbidding it Replied, post #18 · Safety › Contraindications · 28 May 2026 · 6 likes Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #16 · Compounds › Oral incretins · 26 May 2026 · 17 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #40 · Analytics › COA interpretation · 5 May 2026 · 4 likes Coming back to post #38, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
The "under review" status pill and when a moderator applies it Replied, post #93 · Evidence › Preprints · 24 Apr 2026 · 5 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #5 · Analytics › Home & field testing · 19 Apr 2026 · 4 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
The "under review" status pill and when a moderator applies it Replied, post #72 · Evidence › Preprints · 14 Apr 2026 · 12 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #38 · Practice › Administration · 4 Apr 2026 · 0 likes Worth separating two things that post #34 runs together. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up)…
-
Personal import allowances, compared — a second dataset Replied, post #95 · Access › International · 31 Mar 2026 · 0 likes This follows post #92 rather than contradicting it. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #54 · Analytics › Impurities & related substances · 29 Mar 2026 · 10 likes I read post #52 twice before replying, because I had assumed the opposite. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the…
-
Open-label extensions: what survives and what does not Replied, post #3 · Evidence › Trials · 25 Mar 2026 · 5 likes Picking up post #2: that is the part I would want checked first. Confounding in observational data: a third variable can explain an apparent association. In a…
-
Contributing data without breaching anyone's privacy Replied, post #71 · Data & Tools › Datasets · 6 Mar 2026 · 3 likes This follows post #68 rather than contradicting it. Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have…
-
Reading an interaction checker output critically Replied, post #136 · Practice › Interactions · 4 Mar 2026 · 4 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Whether protein timing matters at a large deficit Replied, post #24 · Nutrition & Training › Protein & intake · 10 Feb 2026 · 31 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Heterogeneity as information rather than as a nuisance Replied, post #86 · Evidence › Meta-analyses · 2 Feb 2026 · 1 like Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Specification in the result column: why that is a meaningful error Replied, post #115 · Analytics › COA interpretation · 1 Feb 2026 · 0 likes Picking up post #112: that is the part I would want checked first. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #62 · Sourcing › Red flags · 24 Jan 2026 · 2 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Preprint servers and what screening they do Replied, post #22 · Evidence › Preprints · 12 Jan 2026 · 9 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #51 · Access › International · 12 Jan 2026 · 12 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #18 · Research Methods › N-of-1 designs · 7 Jan 2026 · 31 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #52 · Practice › Side effects · 28 Dec 2025 · 32 likes Picking up post #49: that is the part I would want checked first. Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing…
-
DXA precision and the least significant change for lean mass Replied, post #39 · Outcomes › Body composition · 3 Dec 2025 · 18 likes Worth separating two things that post #35 runs together. Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #15 · Sourcing › Independent verification · 17 Nov 2025 · 0 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
How to read a forest plot, properly, from scratch Replied, post #56 · Evidence › Trials · 16 Nov 2025 · 18 likes I read post #54 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #85 · Start Here › How to Ask · 11 Nov 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #88 · Safety › Adverse events · 3 Nov 2025 · 0 likes Worth separating two things that post #84 runs together. Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious.…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #21 · Clinical › Special populations · 29 Oct 2025 · 0 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #63 · Safety › Adverse events · 27 Oct 2025 · 18 likes Picking up post #60: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
An orphaned page with no inbound links — the long version Replied, post #14 · Meta › Wiki maintenance · 10 Oct 2025 · 0 likes Revision disputes: if you disagree with an edit a maintainer made, discussing it here invites resolution rather than conflict.
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #53 · Compounds › Secretagogues & GH axis · 29 Sep 2025 · 0 likes Worth separating two things that post #49 runs together. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for…
-
Specification in the result column: why that is a meaningful error Replied, post #47 · Analytics › COA interpretation · 21 Sep 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #118 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
About the Home & field testing category Replied, post #4 · Analytics › Home & field testing · 31 Aug 2025 · 0 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #54 · Evidence › Journal club · 18 Aug 2025 · 8 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Reconciling a label claim with a content assay Replied, post #2 · Analytics › COA interpretation · 8 Aug 2025 · 4 likes I read the opening post twice before replying, because I had assumed the opposite. When method identifiers are missing: "reversed-phase HPLC" is less specific than…
-
What this community means by "a source", in practical terms Replied, post #57 · Start Here › Welcome · 3 Aug 2025 · 4 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #27 · Sourcing › Vendor reports · 19 Jul 2025 · 0 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Coming back to: Official shortage notices and what they authorise Replied, post #48 · Access › Shortages · 5 Jul 2025 · 20 likes post #47 is right about the mechanism and I think understates the practical bit. International supply chains: a shortage in one country does not mean shortage in…
-
Repeatability versus intermediate precision Replied, post #48 · Analytics › Method validation · 23 Jun 2025 · 16 likes Picking up post #45: that is the part I would want checked first. Specificity: the method can distinguish the intended compound from related impurities and degradation…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #147 · Compounds › Cagrilintide & amylin analogues · 19 Jun 2025 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #21 · Practice › Reconstitution · 13 Jun 2025 · 9 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Why plausible mechanism is not evidence of effect — one year on Replied, post #5 · Compounds › Repair & healing peptides · 5 Jun 2025 · 22 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #76 · Data & Tools › Calculators · 18 May 2025 · 2 likes post #75 answers the question as asked. The question underneath it is different. Reconstitution calculator: enter vial mass, final volume target, and the calculator…
-
Coverage for the indication versus for the drug Replied, post #64 · Access › Insurance & coverage · 13 May 2025 · 13 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
An orphaned page with no inbound links Replied, post #34 · Meta › Wiki maintenance · 29 Apr 2025 · 2 likes Coming back to post #32, because the follow-up matters more than the original answer. Maintainer handovers: if a page's maintainer is inactive and needs a new one,…
-
Retatrutide dose escalation in the published trials Replied, post #160 · Compounds › Retatrutide · 20 Apr 2025 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Certificates issued by the seller versus by a laboratory Replied, post #44 · Analytics › COA interpretation · 14 Apr 2025 · 19 likes Coming back to post #42, because the follow-up matters more than the original answer. When method identifiers are missing: "reversed-phase HPLC" is less specific than…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #11 · Evidence › Journal club · 25 Mar 2025 · 10 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #122 · Compounds › Semaglutide · 6 Mar 2025 · 15 likes Picking up post #119: that is the part I would want checked first. Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #24 · Outcomes › Progress reports · 6 Mar 2025 · 0 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #31 · Compounds › Tirzepatide · 2 Mar 2025 · 19 likes post #30 answers the question as asked. The question underneath it is different. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Consistent declarations and why they matter more than clever ones Replied, post #18 · Sourcing › Logistics · 11 Feb 2025 · 4 likes On post #14 — agreed on the reasoning, with one qualification. Tracking stops updating: tracking last updated days ago usually means the package is in transit and will…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #30 · Evidence › Meta-analyses · 31 Jan 2025 · 4 likes Worth separating two things that post #26 runs together. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #87 · Analytics › COA interpretation · 30 Jan 2025 · 1 like Coming back to post #85, because the follow-up matters more than the original answer. When a document puts the specification in the result column, it has told you the…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #21 · Compounds › Semaglutide · 9 Jan 2025 · 2 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Follow-up: Individual participant data versus aggregate data Replied, post #17 · Evidence › Meta-analyses · 8 Jan 2025 · 0 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Fibre intake when total intake falls, and the constipation link Replied, post #14 · Nutrition & Training › Protein & intake · 6 Jan 2025 · 32 likes Worth separating two things that post #10 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Oxidation pathways for methionine and tryptophan Replied, post #3 · Analytics › Impurities & related substances · 24 Dec 2024 · 0 likes Picking up post #2: that is the part I would want checked first. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #87 · Compounds › Semaglutide · 24 Dec 2024 · 19 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Isotope patterns and why the monoisotopic peak is not the tallest Replied, post #6 · Analytics › Mass spectrometry · 13 Dec 2024 · 6 likes Picking up post #3: that is the part I would want checked first. Purity and identity are different questions: LC-MS establishes that the species at a retention time has…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #76 · Devices › Syringes & needles · 4 Dec 2024 · 0 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #49 · Clinical › Special populations · 23 Nov 2024 · 17 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #9 · Clinical › Special populations · 19 Nov 2024 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Renal impairment: the compounds are cleared renally to some degree. Dose…
-
Why "any advice?" is the least effective ending for a post Replied, post #48 · Start Here › How to Ask · 18 Nov 2024 · 12 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Revisiting: Moderation log format change Replied, post #29 · Meta › Announcements · 15 Nov 2024 · 24 likes On post #25 — agreed on the reasoning, with one qualification. Feedback to announcements: if you have feedback on an announced change (not a question, but your…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #31 · Evidence › Journal club · 13 Nov 2024 · 8 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Time to steady state after a dose increase Replied, post #84 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 2 likes Worth separating two things that post #80 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Journal club: FLOW and the renal composite, component by component Replied, post #66 · Evidence › Journal club · 15 Jul 2024 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #16 · Clinical › Prescriber conversations · 6 Jul 2024 · 0 likes This follows post #13 rather than contradicting it. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of…
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #19 · Nutrition & Training › Resistance training · 27 Jun 2024 · 6 likes Cardio and resistance: the interaction between energy-intense cardiovascular training and resistance training is real. Moderate cardio is fine; excessive endurance…